Standards; Pharmaceutical/API Drug Impurities/Metabolites; JWH Compounds/Synthetic Cannabinoids;
應(yīng)用:
MDMB-FUBINACA is a derivative of AB-FUBINACA (A603135), an indazole derivative developed as a CB1 receptor modulator used in the treatment of CB1-mediated diseases.Synthetic Cannabinoids